Azoy Alexander, Chief Accounting Officer of Arcus Biosciences ($RCUS), sold shares on the open market six times in the last year, totaling about $300 thousand. His most recent sale occurred on December 18, 2025. These sales rank 7,554th among 11,678 insiders in our database, where the average is $8.6 million across 6.37 transactions. Alexander made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2026 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | A | Stock Option (right to buy) | 14050 | $0.00 | 14,050.0000 | 107,973,536 | 9999.99% | 0.01% |
| Jan. 23, 2026 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | A | Common Stock | 21050 | $0.00 | 39,581.0000 | 107,973,536 | 113.59% | 0.02% |
| Dec. 16, 2025 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | S | Common Stock | 2376 | $21.88 | 24,987.0000 | 107,973,536 | 8.68% | 0.00% |
| Dec. 18, 2025 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | S | Common Stock | 4343 | $22.25 | 18,531.0000 | 107,973,536 | 18.99% | 0.00% |
| Dec. 17, 2025 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | S | Common Stock | 2113 | $22.16 | 22,874.0000 | 107,973,536 | 8.46% | 0.00% |
| Nov. 26, 2025 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | S | Common Stock | 1900 | $26.00 | 27,363.0000 | 107,973,536 | 6.49% | 0.00% |
| Nov. 26, 2025 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | M | Stock Option (right to buy) | 1900 | $0.00 | 9,500.0000 | 107,973,536 | 16.67% | 0.00% |
| Nov. 26, 2025 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | M | Common Stock | 1900 | $13.33 | 29,263.0000 | 107,973,536 | 6.94% | 0.00% |
| Sept. 29, 2025 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | S | Common Stock | 2831 | $13.00 | 27,363.0000 | 105,841,422 | 9.38% | 0.00% |
| Sept. 5, 2025 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | S | Common Stock | 1579 | $11.88 | 30,194.0000 | 105,841,422 | 4.97% | 0.00% |
| Jan. 23, 2025 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | A | Common Stock | 17100 | $0.00 | 30,194.0000 | 0 | 130.59% | 0.00% |
| Jan. 23, 2025 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | A | Stock Option (right to buy) | 11400 | $0.00 | 11,400.0000 | 0 | 9999.99% | 0.00% |
| Dec. 19, 2024 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | D | Common Stock | 3007 | $15.17 | 13,094.0000 | 0 | 18.68% | 0.00% |
| Dec. 15, 2024 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | F | Common Stock | 2969 | $16.08 | 16,101.0000 | 0 | 15.57% | 0.00% |
| Dec. 2, 2024 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | S | Common Stock | 201 | $15.32 | 19,070.0000 | 0 | 1.04% | 0.00% |
| Aug. 13, 2024 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | S | Common Stock | 1357 | $14.97 | 19,070.0000 | 0 | 6.64% | 0.00% |
| Jan. 23, 2024 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | A | Common Stock | 8850 | $0.00 | 19,070.0000 | 0 | 86.59% | 0.00% |
| Jan. 23, 2024 | Arcus Biosciences, Inc. | $RCUS | Azoy Alexander | Chief Accounting Officer | A | Stock Option (right to buy) | 5900 | $0.00 | 5,900.0000 | 0 | 9999.99% | 0.00% |